Cell Therapeutics Inc Sample Contracts
EXHIBIT 10.1 CELL THERAPEUTICS, INC. SERIES A CONVERTIBLE PREFERRED STOCK, without par value STOCK PURCHASE AGREEMENT _________________________Stock Purchase Agreement • November 14th, 1996 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
SEVERANCE AGREEMENT, dated as of September 23, 1997, by and between Cell ------------------ Therapeutics, Inc., a Washington corporation ("CTI"), and Jack W. Singer, MD (the "Executive");Severance Agreement • April 30th, 2001 • Cell Therapeutics Inc • Pharmaceutical preparations • Washington
EXHIBIT 10.5 EMPLOYMENT AGREEMENT -------------------- THIS EMPLOYMENT AGREEMENT (the "Agreement") is entered into as of the 17th day of December, 1996, by and between JAMES A. BIANCO, M.D. ("Employee"), and CELL THERAPEUTICS, INC., a Washington...Employment Agreement • January 31st, 1997 • Cell Therapeutics Inc • Pharmaceutical preparations • Washington
ARTICLE IVoting Agreement • June 26th, 2003 • Cell Therapeutics Inc • Pharmaceutical preparations • Delaware
Exhibit 4.3 WARRANT NO. P-3 DATE OF ISSUANCE: November 24, 1999 WARRANT TO PURCHASE SHARES OF COMMON STOCK OF CELL THERAPEUTICS, INC. This Warrant is issued to ("Purchaser") pursuant to that certain Securities Purchase Agreement dated as of November,...Warrant Agreement • December 30th, 1999 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
Exhibit 1.1 3,000,000 Shares CELL THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT ----------------------Underwriting Agreement • March 24th, 2000 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
EXHIBIT 4.2 CELL THERAPEUTICS, INC. FORM OF REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (the "Agreement") is made as of the 15th day of February, 2000, by and between Cell Therapeutics, Inc., a Washington corporation (the...Registration Rights Agreement • April 12th, 2000 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
AGREEMENT ---------Non-Qualified Stock Option Agreement • September 18th, 1997 • Cell Therapeutics Inc • Pharmaceutical preparations • Washington
RECITALS --------Lease Agreement • January 31st, 1997 • Cell Therapeutics Inc • Pharmaceutical preparations
This Merger Agreement (this "Agreement") is dated January 7, 2000 (the --------- "Effective Date"), and is by and among PolaRx Biopharmaceuticals, Inc., a --------------- company duly organized and existing under the laws of the State of Delaware,...Merger Agreement • January 25th, 2000 • Cell Therapeutics Inc • Pharmaceutical preparations • Delaware
andRights Agreement • November 15th, 1996 • Cell Therapeutics Inc • Pharmaceutical preparations • Washington
2,000,000 Shares CELL THERAPEUTICS, INC. Common Stock (no par value) UNDERWRITING AGREEMENT ----------------------Underwriting Agreement • October 6th, 1997 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
Portions of this Exhibit have been omitted pursuant to a request for confidential treatment. The omitted portions are marked ***** and have been filed separately with the Commission. LICENSE AGREEMENT dated as of November 13, 1998License Agreement • March 31st, 1999 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
AGREEMENT ---------Incentive Stock Option Agreement • November 13th, 1997 • Cell Therapeutics Inc • Pharmaceutical preparations
This Limited Liability Company Agreement (the "Operating Agreement") of ------------------- Cell City, LLC, a limited liability company organized pursuant to the Delaware Limited Liability Company Act, is entered into this 5th day of January, 1998 by...Limited Liability Company Agreement • May 15th, 1998 • Cell Therapeutics Inc • Pharmaceutical preparations • Delaware
ARTICLE IStock Purchase Agreement • March 17th, 1997 • Cell Therapeutics Inc • Pharmaceutical preparations
CELL THERAPEUTICS, INC., as Issuer STATE STREET BANK AND TRUST COMPANY OF CALIFORNIA, N.A., a national banking association, as Trustee INDENTUREIndenture • March 27th, 2003 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
RECITALSRegistration Rights Agreement • November 14th, 1996 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
Exhibit 2.2 AMENDMENT NO. 1 TO MERGER AGREEMENT THIS AMENDMENT NO. 1 TO MERGER AGREEMENT (this "Amendment No. 1"), dated as of March 6, 2003, is being entered into by and among Cell Therapeutics, Inc. a Washington corporation ("CTI"), PolaRx...Merger Agreement • March 27th, 2003 • Cell Therapeutics Inc • Pharmaceutical preparations
Exhibit 10.1 LOAN AGREEMENTLoan Agreement • April 12th, 2002 • Cell Therapeutics Inc • Pharmaceutical preparations • Washington
RECITALSRegistration Rights Agreement • December 30th, 1999 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
EXHIBIT 4.1 EXECUTION COPY -------------- SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (the "Agreement") is entered into as of November 15, 1999 (the "Execution Date"), between Cell Therapeutics, Inc., a Washington corporation (the...Securities Purchase Agreement • December 30th, 1999 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
Sublandlord and Subtenant hereby acknowledge and agree that Area 3 is currently subleased by Subtenant from Sublandlord pursuant to that certain Sublease dated December 4, 2000 (the "Prior Sublease"). Sublandlord and -------------- Subtenant agree...Sublease Agreement • April 30th, 2002 • Cell Therapeutics Inc • Pharmaceutical preparations
RECITALSSupply Agreement • March 17th, 1997 • Cell Therapeutics Inc • Pharmaceutical preparations • Washington
20,000,000 Shares CTI BioPharma Corp. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 12th, 2018 • Cti Biopharma Corp • Pharmaceutical preparations • New York
CELL THERAPEUTICS, INC., as Issuer STATE STREET BANK AND TRUST COMPANY OF CALIFORNIA, N.A., a national banking association, as Trustee INDENTUREIndenture • June 13th, 2001 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
EXHIBIT 10.2 CELL THERAPEUTICS, INC. SERIES A CONVERTIBLE PREFERRED STOCK, without par value STOCK PURCHASE AGREEMENTStock Purchase Agreement • November 14th, 1996 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
EXHIBIT 10.6 ELLIOTT BAY OFFICE PARK OFFICE LEASEOffice Lease • March 31st, 1999 • Cell Therapeutics Inc • Pharmaceutical preparations • Washington
INDEMNIFICATION AGREEMENTIndemnification Agreement • January 24th, 2018 • Cti Biopharma Corp • Pharmaceutical preparations • Delaware
This Indemnification Agreement ("Agreement"), dated as of the Effective Date, is entered by and between CTI BioPharma Corp., a Delaware corporation (the "Company"), and ______________ ("Indemnitee"). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering the subject matter of this Agreement.
EXHIBIT 4.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (the "Agreement") is entered into as of February 15, 2000 (the "Execution Date"), between Cell Therapeutics, Inc., a Washington corporation (the "Company"), and the investors...Securities Purchase Agreement • April 12th, 2000 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
3,130,435 Shares CELL THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT ----------------------Underwriting Agreement • September 22nd, 2000 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
EXHIBIT 10.4 [LETTERHEAD OF CTI] September 6, 1996 HAND DELIVERED -------------- Mr. David A. Sabey Sabey Corporation 101 Elliott Avenue West, Suite 330 Seattle, WA 98119 Re: Lease Amendment --------------- Dear Dave: Cti acknowledges that the Office...Lease Amendment • January 31st, 1997 • Cell Therapeutics Inc • Pharmaceutical preparations
OPEN MARKET SALE AGREEMENTSMOpen Market Sale Agreement • August 17th, 2022 • Cti Biopharma Corp • Pharmaceutical preparations • New York
COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of CELL THERAPEUTICS, INC.Common Stock Purchase Warrant • March 5th, 2008 • Cell Therapeutics Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the 120th day following the Closing Date (the “Initial Exercise Date”) and on or prior to the close of business on the 3 year anniversary following the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cell Therapeutics, Inc., a Washington corporation (the “Company”), up to shares* (the “Warrant Shares”) of common stock, no par value per share (the “Common Stock”), of the Company. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
ISDA(R)Isda Master Agreement • March 29th, 2002 • Cell Therapeutics Inc • Pharmaceutical preparations • New York